Exact Mass: 382.2636674
Exact Mass Matches: 382.2636674
Found 86 metabolites which its exact mass value is equals to given mass value 382.2636674,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Misoprostol
Misoprostol is only found in individuals that have used or taken this drug. It is a synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. [PubChem]Misoprostol seems to inhibit gastric acid secretion by a direct action on the parietal cells through binding to the prostaglandin receptor. The activity of this receptor is mediated by G proteins which normally activate adenylate cyclase. The indirect inhibition of adenylate cyclase by Misoprostol may be dependent on guanosine-5’-triphosphate (GTP). The significant cytoprotective actions of misoprostol are related to several mechanisms. These include: 1. Increased secretion of bicarbonate, 2. Considerable decrease in the volume and pepsin content of the gastric secretions, 3. It prevents harmful agents from disrupting the tight junctions between the epithelial cells which stops the subsequent back diffusion of H+ ions into the gastric mucosa, 4. Increased thickness of mucus layer, 5. Enhanced mucosal blood flow as a result of direct vasodilatation, 6. Stabilization of tissue lysozymes/vascular endothelium, 7. Improvement of mucosal regeneration capacity, and 8. Replacement of prostaglandins that have been depleted as a result of various insults to the area. Misoprostol has also been shown to increase the amplitude and frequency of uterine contractions during pregnancy via selective binding to the EP-2/EP-3 prostanoid receptors. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BB - Prostaglandins G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins C26170 - Protective Agent > C2459 - Chemoprotective Agent > C2080 - Cytoprotective Agent C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue
(11R,16S)-misoprostol
13,14-Dihydro-15-keto-20-ethyl prostaglandin f2alpha
Carboprost methyl
2,6,10,14-Tetramethyl-6,10,15-hexadecatriene-2,3,8,14-tetrol 8-acetate
rel-(3R,5S)-5-{(1R,5Z,9E)-5-[(acetyloxy)methyl]-11-hydroxy-1,9-dimethylundeca-5,9-dien-1-yl}tetrahydro-2,2-dimethylfuran-3-ol
3-hydroxy-2-(hydroxymethyl)-4-(14-methylhexadecanoyl)-2H-furan-5-one
(2E,6Z,12S,13E)-7-[(acetyloxy)methyl]-3,11,15-trimethylhexadeca-2,6,13-triene-1,12,15-triol
(2E,6Z,12R,14S)-7-[(acetyloxy)methyl]-3,11,15-trimethylhexadeca-2,6,15-triene-1,12,14-triol
7-[3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoic acid
Unoprostone
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78568 - Prostaglandin Analogue
(5-ethyl-1-azabicyclo[2.2.2]octan-2-yl)-[6-(3-methylbutoxy)quinolin-4-yl]methanol
Carboprost methylate
Urea, N-cyclohexyl-N-cyclopentyl-N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]- (9CI)
Methyl (8β,11α,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
(11R,16S)-misoprostol
D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics
Misoprostol
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BB - Prostaglandins G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins C26170 - Protective Agent > C2459 - Chemoprotective Agent > C2080 - Cytoprotective Agent C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue
methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
(E)-7-[3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoic acid
[3-carboxy-2-[(5E,7E,9E)-3-hydroxytetradeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(6E,9E,12E)-3-hydroxytetradeca-6,9,12-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(7E,9E,11E)-3-hydroxytetradeca-7,9,11-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(8E,10E,12E)-3-hydroxytetradeca-8,10,12-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(6E,8E,10E)-3-hydroxytetradeca-6,8,10-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(5E,8E,11E)-3-hydroxytetradeca-5,8,11-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(4E,6E,8E)-3-hydroxytetradeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(4E,10E,12E)-3-hydroxytetradeca-4,10,12-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-carboxy-2-[(4E,7E,10E)-3-hydroxytetradeca-4,7,10-trienoyl]oxypropyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
[3-Carboxy-2-[3-(3,4-dimethyl-5-pentylfuran-2-yl)propanoyloxy]propyl]-trimethylazanium
C21H36NO5+ (382.25933460000005)
2-[(2S,3R,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
2-[(2R,3S,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
2-[(2S,3S,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide
1-[(2R,3R)-1-(cyclopentylmethyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]propan-1-one
2-[(2R,3S,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
2-[(2S,3R,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
2-[(2S,3S,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
2-[(2R,3R,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
2-[(2R,3R,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C19H34N4O4 (382.25799240000003)
N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide
1-[(2S,3S)-1-(cyclopentylmethyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]propan-1-one
(1-hydroxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-acetyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
9-oxo-11R,15S-dihydroxy-1a,1b-dihomo-13E-prostaenoic acid
DG(19:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved